Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
    • PYQ Mastery Program
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
      • PYQ Mastery Program
    • Portal Login

    TB TEST FEOM URINE SAMPLE

    • December 13, 2020
    • Posted by: OptimizeIAS Team
    • Category: DPN Topics
    No Comments

    Subject: Science & tech

    Context: IIT Madras researchers are developing a point-of-care platform for early-stage TB screening and detection using urine samples. The platform is yet to be tested in clinical trials.

    Concept:

    • Diagnosing TB usually involves using a sputum sample or a biopsy in the detection tests. This is not just time-consuming or expensive, there are also cases where getting a sputum sample is not easy or even possible, such as with small children or in the case of extra pulmonary TB.

    Process:

    • The glycolipid lipoarabinomannan (LAM), an integral component of the cell wall and cell membrane of Mycobacterium tuberculosis (Mtb), the disease-causing bacterium, has been explored as a biomarker for TB diagnosis.
    • Since it is known that LAM is released into the blood stream during active infection and passed out in urine, it can be viewed as a potential biomarker for even cases other than pulmonary TB.
    Science and tech TB TEST FEOM URINE SAMPLE
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search